The use of mesenchymal stromal cells in treatment of lung disorders.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Regenerative medicine

• Publication date

  2017-02-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/rme-2016-0112PMID 28244823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aerosol‐based airway epithelial cell delivery improves airway regeneration and repair

  2018cited by this paper
• Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases

  2016cited by this paper
• Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model

  2016cited by this paper
• Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence

  2016cited by this paper
• Paracrine effects of TLR4-polarised mesenchymal stromal cells are mediated by extracellular vesicles

  2016cited by this paper
• Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?

  2016cited by this paper
• Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines

  2016cited by this paper
• A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.

  2016cited by this paper
• The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration.

  2016cited by this paper
• Generation of Osteosarcomas from a Combination of Rb Silencing and c‐Myc Overexpression in Human Mesenchymal Stem Cells

  2016cited by this paper
• Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study

  2016cited by this paper
• In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome

  2015cited by this paper
• Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta‐ defensin‐ 2 via toll‐ like receptor 4 signalling

  2015cited by this paper
• Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases

  2015cited by this paper
• Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

  2015cited by this paper
• Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat

  2015cited by this paper
• Therapeutic Efficacy of Human Mesenchymal Stromal Cells in the Repair of Established Ventilator-induced Lung Injury in the Rat

  2015cited by this paper
• Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome: A Light at the End of the Tunnel?

  2015cited by this paper
• Controversial Role of Toll-like Receptor 4 in Adult Stem Cells

  2015cited by this paper
• LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b

  2015cited by this paper
• Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways

  2015cited by this paper
• Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications

  2014cited by this paper
• Are Clinical Trials With Mesenchymal Stem/Progenitor Cells too Far Ahead of the Science? Lessons From Experimental Hematology

  2014cited by this paper
• Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial.

  2014cited by this paper
• Aerosol delivery of synthetic lung surfactant

  2014cited by this paper
• Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices

  2014cited by this paper
• Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study

  2014cited by this paper
• Secretion of immunoregulatory cytokines by mesenchymal stem cells.

  2014cited by this paper
• Aerosol-Based Delivery of Fibroblast Cells for Treatment of Lung Diseases

  2014cited by this paper
• Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells

  2014cited by this paper
• Clinical applications of mesenchymal stem cells

  2013cited by this paper
• MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation

  2013cited by this paper
• Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes.

  2013cited by this paper
• A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.

  2013cited by this paper
• Mesenchymal stem cells protect cigarette smoke‐damaged lung and pulmonary function partly via VEGF–VEGF receptors

  2013cited by this paper
• Intravenous and Intratracheal Mesenchymal Stromal Cell Injection in a Mouse Model of Pulmonary Emphysema

  2013cited by this paper
• Prolonged cultivation of hippocampal neural precursor cells shifts their differentiation potential and selects for aneuploid cells

  2013cited by this paper
• Adult stem cells for chronic lung diseases

  2013cited by this paper
• Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion

  2012cited by this paper
• Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

  2012cited by this paper
• Autologous Lung-Derived Mesenchymal Stem Cell Transplantation in Experimental Emphysema

  2012cited by this paper
• Mesenchymal stromal cells (MSCs): science and f(r)iction

  2012cited by this paper
• Clinical applications of mesenchymal stem cells

  2012cited by this paper
• Microfabricated Engineered Particle Systems for Respiratory Drug Delivery and Other Pharmaceutical Applications

  2012cited by this paper
• Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity.

  2012cited by this paper
• Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma.

  2011cited by this paper
• Mesenchymal Stem Cell Transfer Suppresses Airway Remodeling in a Toluene Diisocyanate-Induced Murine Asthma Model

  2011cited by this paper
• Risk factors in the development of stem cell therapy

  2011cited by this paper
• Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

  2011cited by this paper
• An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.

  2011cited by this paper
• Malignant Tumor Formation After Transplantation of Short-Term Cultured Bone Marrow Mesenchymal Stem Cells in Experimental Myocardial Infarction and Diabetic Neuropathy

  2011cited by this paper
• Safety of Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Animals and Humans

  2011cited by this paper
• Contribution of Neutrophils to Acute Lung Injury

  2011cited by this paper
• Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat

  2011cited by this paper
• Mesenchymal Stem Cells Restore Lung Function by Recruiting Resident and Nonresident Proteins

  2011cited by this paper
• Repeated invasive lung function measurements in intubated mice: an approach for longitudinal lung research

  2011cited by this paper
• Pulmonary Function Tests

  2011cited by this paper
• IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice.

  2011cited by this paper
• Experimental Models and Emerging Hypotheses for Acute Lung Injury

  2011cited by this paper
• Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases.

  2010cited by this paper
• A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype

  2010cited by this paper
• Bone Marrow Mesenchymal Stromal Cells Attenuate Organ Injury Induced by LPS and Burn

  2010cited by this paper
• Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment

  2010cited by this paper
• Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy

  2010cited by this paper
• Neural Stem Cells Adopt Tumorigenic Properties by Constitutively Activated NF-κB and Subsequent VEGF Up-Regulation

  2010cited by this paper
• Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

  2010cited by this paper
• Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

  2010cited by this paper
• Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients

  2010cited by this paper
• GMP-Compliant Propagation of Human Multipotent Mesenchymal Stromal Cells

  2010cited by this paper
• Stem cells and cell therapy approaches in lung biology and diseases

  2010cited by this paper
• Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL‐37

  2010cited by this paper
• Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model.

  2010cited by this paper
• Therapeutic potential of mesenchymal stem cells for severe acute lung injury.

  2010cited by this paper
• Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats.

  2009cited by this paper
• FDA Regulation of Stem Cell–Based Products

  2009cited by this paper
• Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.

  2009cited by this paper
• Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect

  2009cited by this paper
• Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

  2009cited by this paper
• Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.

  2009cited by this paper
• MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

  2009cited by this paper
• Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant.

  2008cited by this paper
• Novel methods for delivery of cell-based therapies.

  2008cited by this paper
• Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open‐label pilot study

  2008cited by this paper
• Mesenchymal stem cells transplantation protects against rat pulmonary emphysema.

  2008cited by this paper
• Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies.

  2008cited by this paper
• VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

  2008cited by this paper
• Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation

  2008cited by this paper
• Targeted cell replacement with bone marrow cells for airway epithelial regeneration.

  2007cited by this paper
• Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

  2007cited by this paper
• Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

  2007cited by this paper
• “Stemness” Does Not Explain the Repair of Many Tissues by Mesenchymal Stem/Multipotent Stromal Cells (MSCs)

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice.

  2007cited by this paper
• Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.

  2007cited by this paper
• No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients

  2007cited by this paper
• Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial.

  2007cited by this paper
• Immunomodulatory properties of mesenchymal stromal cells.

  2007cited by this paper
• Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1

  2007cited by this paper
• Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.

  2007cited by this paper
• Stem cell transplantation: the lung barrier.

  2007cited by this paper

• Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies

  2025cites this paper
• MiR-148a-3p within HucMSC-Derived Extracellular Vesicles Suppresses Hsp90b1 to Prevent Fibroblast Collagen Synthesis and Secretion in Silica-Induced Pulmonary Fibrosis

  2023cites this paper
• Therapeutic Potential of Adipose-Derived Stem Cells in the Treatment of Pulmonary Diseases.

  2021cites this paper
• Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use

  2020cites this paper
• Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.

  2019cites this paper
• Dissecting the Pharmacodynamics and Pharmacokinetics of MSCs to Overcome Limitations in Their Clinical Translation

  2019cites this paper
• Aerosolised Mesenchymal Stem Cells Expressing Angiopoietin-1 Enhances Airway Repair

  2018cites this paper
• Mesenchymal stem cell in wound healing and regeneration.

  2017cites this paper
• Patient-Centered (P4) Medicine and the Older Person.

  2017cites this paper